Fueling Scientific Advancement: Fostering Innovation and Competitiveness in the Pharmaceutical Sector
Time goes by, years change, in a blink of an eye, the busy year has passed. With passion and challenge, a new year is coming. On the occasion of the New Year's Day, Chenghui Shuangda's 2018 recognition conference was held on January 28 at the Ni's Haitai Hotel in Jinan. The conference invited many partners and Chenghui Shuangda employees to gathering together.
The General Office of the State Council recently issued the Guiding Opinions on Further Deepening the Reform of the Payment Method for Basic Medical Insurance(hereinafter referred to as the Opinions), proposing to further strengthen the budget management of the medical insurance fund from 2017 onwards. The multivariate compound payment method based on disease payment is fully implemented. Experts believe that the medical insurance payment system reform will become the key mechanism of medical service cost control under the premise that the medical insurance market has been formed in our country and medical insurance payment has become the main source of compensation for public hospitals.
Xi Jinping, General Secretary of the CPC Central Committee, President of the State Council, Chairman of the Central Military Commission and Chairman of the Central Committee's Comprehensive Reform Leading Group, presided over the 37th meeting of the Central Committee's Comprehensive Reform Leading Group on the afternoon of July 19 and delivered an important speech.
The company has a complete quality assurance system and strong scientific research and innovation capabilities. Every year, new synthetic drugs that are market-oriented and have a high technical content are launched. We are willing to provide you with high quality products and competitive price.
We have always been guided by scientific research, market orientation, and the development of pharmaceutical technology as the center. We have opened the industrial chain of research and development, production and sales, and have presented a pattern of integrated development of science, technology and trade.
Shandong Chenghui Shuangda Pharmaceutical Co. Ltd. is a high-end comprehensive industrial base with raw materials, preparations, food and feed additives as its supplement, meeting international certification and registration standards. The main varieties are five series of local anesthesia drugs, cardiovascular system drugs, nutritional drugs, hormone drugs, and food additives. Some of the varieties are among the world's 2-3 main suppliers. The company has a world-class first-class production line, meets GMP, FDA and other relevant certification requirements, builds six workshops and eight production lines that meet GMP production, and is equipped with R&D and transformation experimental platforms and quality analysis control centers that meet the requirements of CGMP.